Dear Members of the UCSF Community:

I am pleased to share the exciting news that Priscilla Chan, MD, and Facebook founder Mark Zuckerberg, have committed $600 million to establish the Chan Zuckerberg Biohub, a venture designed to create synergy among the UCSF, Stanford University, and UC Berkeley research enterprises, with the goal of advancing discovery in the health sciences.

An independent non-profit entity, Biohub will be based at 499 Illinois Street, adjacent to the UCSF Mission Bay campus, and will be co-directed by Joe DeRisi, PhD, UCSF professor and chair of biochemistry and biophysics, and Stanford’s Steve Quake, DPhil, professor of bioengineering and of applied physics.

Biohub is the first philanthropic science investment made by the Chan Zuckerberg Initiative, and is an extraordinary opportunity to capitalize on our region’s unparalleled strength in technological and biomedical innovation in the service of improving health locally and worldwide.

It is just one part of an emphasis on science being launched by the Chan Zuckerberg Initiative. That overall program will be led by Cori Bargmann, PhD, the Torsten N. Wiesel Professor, head of the Lulu and Anthony Wang Laboratory of Neural Circuits and Behavior, and Howard Hughes Medical Institute investigator at The Rockefeller University.

One of the world’s leading neuroscientists, Cori was a member of our faculty from 1991 to 2004, and rose to the position of vice chair of the Department of Anatomy. In her new position, she will work out of 499 Illinois Street, so her new role represents a homecoming of sorts, and I know you will join me in welcoming her back to San Francisco.

Finally, as many of you know, Priscilla Chan is a pediatrician who earned her medical degree and did her residency at UCSF. In 2015, she and Mark donated $75 million to our partner hospital San Francisco General Hospital and Trauma Center, now known as Zuckerberg San Francisco General. We are deeply grateful for their vision and generosity.

To learn more about the ground breaking venture of Biohub, the opportunities for established and early-career basic and clinical scientists, and Joe’s vision for the Biohub, please go to


Sam Hawgood, MBBS
Arthur and Toni Rembe Rock Distinguished Professor